With 2.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.23 million shares. The 52-week range on DNA shows that it touched its highest point at $22.60 and its lowest point at $5.00 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at 1.29.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DNA was up-trending over the past week, with a rise of 29.37%, but this was up by 17.69% over a month. Three-month performance surged to 47.07% while six-month performance fell -16.12%. The stock lost -52.44% in the past year, while it has lost -0.41% so far this year. A look at the trailing 12-month EPS for DNA yields -8.99 with Next year EPS estimates of -4.05. For the next quarter, that number is -1.46. This implies an EPS growth rate of 46.09% for this year and 28.73% for next year. EPS is expected to grow by 57.48% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -27.97%.
Float and Shares Shorts:
At present, 43.08 million DNA shares are outstanding with a float of 37.41 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DNA since 5 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 2 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$9.70062 being high and -$10.443 being low. For DNA, this leads to a yearly average estimate of -$10.08.
